Should You Buy Oklo Before Its 2028 Reactor Start-Up?

Oklo achieved low-power criticality at Groves and has billions of dollars in cash to pursue its nuclear ambitions. The key test is converting that progress into licensed Aurora power, meaningful revenue and long-term shareholder value; its targeted 2028 start-up, fuel strategy and growing share count are cited as factors that could shape the stock.

Analysis

Low-power criticality is a technical de-risking event, not proof of a licensed, financeable commercial plant. The gap between demonstration progress and contracted electricity revenue remains the key valuation risk: permitting, fuel availability, construction execution, and customer economics can each move the schedule or capital requirement. A 2028 target leaves limited room for slippage; delays could hit twice by pushing cash flows out and increasing the probability of further share issuance. Conversely, evidence of a credible licensing path and funded fuel supply would make the milestone more economically meaningful.

Over the next 1–3 months, treat the story as catalyst-driven rather than a change in earnings power; verify regulatory milestones, project-level commitments, cash burn, and diluted share count before underwriting the timeline. Over 6–18 months, successful licensing and fuel procurement could support a differentiated advanced-nuclear premium, while incumbent generators with operating assets retain the advantage of monetizable power today. The contrarian risk is that investors either capitalize a technical milestone too quickly or dismiss it entirely: neither view is justified without evidence that the project can progress from reactor status to permitted, financed generation. The thesis weakens materially on a missed regulatory or fuel milestone, a schedule reset, or dilution accelerating without corresponding project de-risking.

Key Decisions for Investors

• Avoid adding to OKLO solely on the criticality milestone; wait for independently verifiable licensing progress, a defined fuel pathway, and project-level commercial commitments before treating the 2028 target as investable cash-flow visibility.
• Set an alert for the next filings and guidance: track cash burn, fully diluted share count, regulatory milestones, and any schedule change. Faster dilution or a delayed licensing path would be a bearish catalyst; credible fuel and customer commitments would be a positive thesis update.
• No standalone directional trade is justified from this information without current valuation and options data. If considering a relative-value position, compare OKLO with established nuclear power exposure only after checking the valuation spread and volatility; do not assume the technical milestone has translated into revenue.